BioWorld MedTech

April 18, 2016

Vertos prods CMS for another look at national coverage decision of PILD

Vertos Medical Inc. has requested that the CMS reopen a national coverage decision after only two years, a move that could open the procedure up to millions of Medicare beneficiaries in the years ahead. Read More

Illumina commits $100M to new VC firm founded by former company exec

SEM Scanner set to ease the pressure in the Canadian wound care market

Elekta bets future on game-changer in radiotherapy

Other News to Note

Daily M&A

Financings

Regulatory Front

Keeping you up to date on recent developments in neurology

Today's news in brief

BioWorld

BioWorld briefs for July 8, 2026.

3D rendering of an antibody drug conjugate

‘Target-high but uptake-defective’ state identified in ADC resistance

BioWorld

Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...

Illustration of brain and brain waves, concept of focal seizure

Hyperexcitability may be joint problem in epilepsy, dementia

BioWorld

The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...

Modius Spero wearable neuromodulation device

Neurovalens granted FDA approval for PTSD therapy for US veterans

BioWorld

Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...

GDE4 blockade promotes remyelination, study finds

BioWorld Science

Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...